Managers / Q2 2024 · view latest →
Noked Israel Ltd
CIK 0001767750 · 22 HAGEFEN ST, RAMAT HASHARON, L3, 4725422 · 972-73-780-3400
Summary
Noked Israel Ltd reported $362M in U.S.-listed holdings across 15 positions for Q2 2024.
Its largest position, TSM, represents 19.0% of the portfolio.
Compared with Q1 2024, the fund opened 2 new positions and exited 9.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 71.6% · $259M
- ADR · 26.5% · $96M
- ETP · 1.6% · $6M
- Other · 0.3% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TEVATEVA PHARMACEUTICAL INDS LTD | NEW | +1.69M | 1.69M | +$27M | $27M |
| WIX COM LTD | NEW | +130 | 130 | +$551,000 | $551,000 |
| TSMTAIWAN SEMICONDUCTOR MFG LTD | ADDED | +257.3K | 395.3K | +$50M | $69M |
| MNDYMONDAY COM LTD | SOLD OUT | −115.5K | 0 | −$26M | $0 |
| TEVA PHARMACEUTICAL INDS LTD | SOLD OUT | −1.49M | 0 | −$21M | $0 |
| CYBERARK SOFTWARE LTD | SOLD OUT | −66.4K | 0 | −$18M | $0 |
| SQUARESPACE INC | SOLD OUT | −341.5K | 0 | −$12M | $0 |
| NVDANVDIA CORPORATION | SOLD OUT | −13.4K | 0 | −$12M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | TSMTAIWAN SEMICONDUCTOR MFG LTDhistory → | SPONSORED ADS | 18.96% | $69M | 395.3K |
| 2 | MSFTMICROSOFT CORPhistory → | COM | 17.02% | $62M | 138.0K |
| 3 | GOOGALPHABET INChistory → | CAP STK CL C | 12.16% | $44M | 240.2K |
| 4 | AMZNAMAZON COM INChistory → | COM | 11.16% | $40M | 209.2K |
| 5 | WIXWIX COM LTD | SHS · CALL | 8.62% | $31M | 193.1K |
| 6 | TEVATEVA PHARMACEUTICAL INDS LTDhistory → | SPONSORED ADS | 7.56% | $27M | 1.69M |
| 7 | METAMETA PLATFORMS INChistory → | CL A | 7.55% | $27M | 54.3K |
| 8 | BKNGBOOKING HOLDINGS INChistory → | COM | 5.68% | $21M | 5.2K |
| 9 | IBKRINTERACTIVE BROKERS GROUP INhistory → | COM CL A | 3.89% | $14M | 115.0K |
| 10 | AAPLAPPLE INChistory → | COM | 3.50% | $13M | 60.2K |
| 11 | CRMSALESFORCE INChistory → | COM | 2.13% | $8M | 30.0K |
| 12 | QQQINVESCO QQQ TR | UNIT SER 1 | 0.92% | $3M | 6.9K |
| 13 | SPYSPDR S&P 500 ETF TR | TR UNIT | 0.72% | $3M | 4.8K |
| 14 | XTL BIOPHARMACEUTICALS LTD | SPONSORED ADR NE | 0.13% | $483,000 | 198.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $677M | 13 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $624M | 14 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $639M | 14 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $542M | 12 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $436M | 15 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $508M | 16 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $458M | 18 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $362M | 15 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $372M | 22 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $379M | 31 | Feb 15, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2023 | $330M | 28 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $292M | 35 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $230M | 22 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $262M | 27 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $411M | 50 | Dec 27, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2022 | $435M | 48 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $329M | 42 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $407M | 45 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $425M | 46 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $401M | 35 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $307M | 33 | May 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $243M | 27 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $151M | 22 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $140M | 16 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $56M | 14 | May 27, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2019 | $89M | 58 | Feb 18, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $95M | 38 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $82M | 81 | Aug 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $96M | 72 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Noked Capital LTD028-19105
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.